Unknown Manufacturer
NS3728 is an orally active chloride channel blocker for the treatment of cancer.
NS3728 is an orally active chloride channel blocker for the treatment of cancer.
NS-3728 (Endovion) blocks a certain subtype of chloride ion channels important for cell division, cell migration and the formation of new blood vessels (angiogenesis).
Investigated for use/treatment in anemia (sickle cell) and cancer/tumors (unspecified).
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
No patents found under this name
Patent documents usually refer to a drug by its chemical name or development code rather than its generic name, and applications are only published about 18 months after filing — so a newer drug may not appear here yet.
